Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
Clinical trial NCT01142232 · COMPLETED
Trial details
- NCT number
- NCT01142232
- Sponsor
- Attaya Suvannasankha
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-27
- Primary completion
- 2015-11-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.